Remarkably, the beneficial potential of dietary compounds for improving lipid-associated cardiovascular risk has been highlighted in food supplements derived from red seaweed marine algae, where porphyrin and carrageenan, the latter being a LOX-1 antagonist, improved lipid metabolism, reduced oxidative stress, protected against hyperlipidemia, and lowered total and low-density lipoprotein cholesterol [95]. The gene discussed is OLR1; the disease is hyperlipidemia.